Truist slashes price target on Cano Health Inc. [CANO] – find out why.


Cano Health Inc. [NYSE: CANO] It traded at the highest level on 09/22/22, posting a gain of 32.17 and after that it closed the day’s session at $8.34. Company report on September 12, 2022 Cano Health participates in the 20th Annual World Health Care Conference at Morgan Stanley.

Top 5 cheap stocks to own right now

While finding safe stocks with the potential for huge gains isn’t always easy, we’ve found a few that can pay off well. In fact, within our report, Top 5 cheap stocks to own right nowIn this article, we have identified five stocks that we believe can increase in value even if you have $1,000 to invest.

Register here to get a free report now. .

sponsored by

Cano Health Inc. announced. (“Cano” or “the Company”) (NYSE: CANO), the leading value-based primary care provider and population health company, today announced that it will participate in the 20th Annual Morgan Stanley Healthcare Conference on Tuesday, September 13 2022. Dr. Marlo Hernandez, Chairman and CEO, and Brian Kobe, Chief Financial Officer, will participate in a conversation at 4:05 PM ET.

The live webcast can be accessed through the Cano Health Investor Relations website at The webcast will be archived for replay after the conference.

The results of the trading session contributed to the circulation of more than 23724014 shares. Over the past week, the price volatility of Cano Health Inc. 17.61% while volatility over the last month was 10.15%.

CANO shares have a market capitalization of $4.28 billion, with 210.05 million shares outstanding and 157.81 million shares in current float. Compared to an average trading volume of 4.02 million shares, CANO had a trading volume of 23724014 on the last trading day, which is why market watchers consider the stock to be active.

What Top Market Experts Say About Cano Health Inc. [CANO]?

Based on careful and fact-backed analysis by Wall Street experts, the current consensus on a target price for CANO shares is $9.26 per share. Target price analysis and stock performance are usually carefully studied by market experts, and the current Wall Street consensus for CANO stock is a set recommendation at 2.00. This rating represents a strong buy recommendation, on a scale of 1 to 5, where 5 means strong sell, 4 represents sell, 3 represents hold, and 2 indicates buy.

Trust has made an estimate for the shares of Cano Health Inc. , retaining their opinion of the stock as Hold, with their previous recommendation back on September 7, 2022. While these analysts held the previous recommendation, Raymond James raised the target price to Outperform. The new note about price target was released on June 24, 2022, which is the official target price for Cano Health Inc.’s stock. Previously, the target price had fallen again from $8 to $6, while BofA Securities maintained a neutral rating on CANO stock.

The Average True Range (ATR) was set by Cano Health Inc. at 0.71, with CANO’s price-to-sales ratio for the last 12-month period at 1.84. The price-to-book ratio for the most recent quarter was 4.26, with the price-to-cash-to-cash ratio for the same quarter set at 0.09.

How has CANO’s stock been performing lately?

Cano Health Inc. [CANO] It made gains in the green at the end of last week, gained a positive trend and rose by 18.97. With this latest performance, CANO shares are up 38.08% over the past four-week period, as well as up 26.17% over the past six months — not to mention a -42.44% drop in the past year of trading.

Overbought and oversold stocks can be easily tracked by the Relative Strength Index (RSI), where an RSI result of over 70 is overbought, and any price below 30 indicates oversold conditions. The RSI of 50 represents neutral momentum in the market. The current RSI for the CANO stock for the last two weeks was set at 69.49, with the RSI for the last one traded at 74.73, and the three-week RSI was set at 65.84 for Cano Health Inc. [CANO]. The current moving average for the last 50 trading days for this stock is 6.10 while it recorded at 6.84 for the last trading week, and 6.15 for the last 200 days.

Cano Health Inc. [CANO]: A deeper look into the basics

Operating margin for any stock indicates how profitable the investment is, Cano Health Inc. [CANO] The equity’s current operating margin is -5.89 and the gross margin is +9.29. Net margin reported to Cano Health Inc. Currently at -1.12.

The return on equity for this stock fell to -4.03, with the return on assets remaining at -1.27.

Cano Health Inc.’s liquidity data is Interesting too, as the current ratio is set at 2.00.

Business Insider Stands for Cano Health Inc. [CANO]

There are currently approximately $1,386 million, or 73.50% of CANO’s stock, in the hands of institutional investors. The three largest CANO shareholders are: FMR LLC with ownership of 31,162,099, which represents approximately 3.826% of the company’s market capitalization and approximately 18.30% of the total institutional ownership; JPMORGAN CHASE & CO, which owns 16,160,541 shares with an approximate value of $134.78 million in CANO stock; and VANGUARD GROUP INC., currently hold $132.06 million in CANO shares with ownership of approximately 24.397% of the company’s market capitalization.

Positions in shares of Cano Health Inc. have increased. held by institutional investors at the end of August and at the time of the August report, as 78 institutional owners consolidated their positions in Cano Health Inc. [NYSE:CANO] About 4,146,695 shares. In addition, 80 investors decreased their positions by 30,259,012 shares, while 22 investors held positions with 94,424,014 shares. The said changes put institutional holdings at 166,149,721 shares, according to the latest report from the Securities and Exchange Commission. Kanoo’s shares had 35 new institutional investors with a total of 5,712,514 shares, while 33 institutional investors sold positions worth 16,072,397 shares during the same period.

Leave A Reply

Your email address will not be published.